{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:33Z","timestamp":1761518913139,"version":"3.35.0"},"reference-count":45,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T00:00:00Z","timestamp":1224028800000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Preventive Cardiology"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p><jats:italic>As presented previously in Part 1 of this 2\u2010part article, many long\u2010term clinical trials provide overwhelming evidence of the benefits of angiotensin\u2010converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) across the cardiovascular continuum. Trials also indicate additive or synergistic effects of combination therapy in renal disease and heart failure. Part 2, which is presented here, discusses the extensive interaction of the renin\u2010angiotensin system (RAS) with the cellular and molecular pathophysiology of cardiovascular disease and the cross\u2010continuum effects of ARBs and ACE inhibitors, which raises the possibility that RAS inhibition can offer protection in high\u2010risk patients who do not have symptoms. Although trial evidence supports the effectiveness of monotherapy, the benefits of combined ACE inhibitor\/ARB therapy in high\u2010risk patients await confirmation. Ongoing clinical research will provide new and important information regarding the efficacy of specific combination (ACE inhibitor\/ARB) therapies.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1751-7141.2008.00004.x","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T18:15:35Z","timestamp":1224094535000},"page":"215-222","source":"Crossref","is-referenced-by-count":6,"title":["Use of Angiotensin\u2010Converting Enzyme Inhibitor\/Angiotensin Receptor Blocker Therapy to Reduce Cardiovascular Events in High\u2010Risk Patients: Part 2"],"prefix":"10.1111","volume":"11","author":[{"given":"William J.","family":"Bommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,15]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-006-9799-9"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198211000-00014"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-000-0077-3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199208000-00015"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.034"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"De Gasparo M","year":"2000","journal-title":"Pharmacol Rev."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.11.032"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00103-X"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60242-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004060492"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-005-5059-7"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/08037050510034211"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006070770"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00290.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00846-5"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00123.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000220101.57896.cd"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280287a72"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2006.11.008"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.01.018"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001053"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.38.3.434"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280ac1533"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.5.1034"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200212000-00022"},{"key":"e_1_2_6_27_2","first-page":"1053","article-title":"Comparative evaluation of ACE inhibitors: which differences are relevant? [in German]","volume":"129","author":"Fischler MP","year":"1999","journal-title":"Schweiz Med Wochenschr."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000991"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2000.tb00039.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14286-9"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.7.919"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042739"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.01.032"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.18.2217"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00230-3"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69201-5"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.05.011"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.38.2.183"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60669-2"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60643-6"}],"container-title":["Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7141.2008.00004.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-7141.2008.00004.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:23:55Z","timestamp":1738448635000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7141.2008.00004.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1751-7141.2008.00004.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-7141.2008.00004.x","archive":["Portico"],"relation":{},"ISSN":["1520-037X","1751-7141"],"issn-type":[{"type":"print","value":"1520-037X"},{"type":"electronic","value":"1751-7141"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}